BÜHLMANN is the world’s EXPERT for CALPROTECTIN laboratory tests. The turbidimetric BÜHLMANN fCAL® turbo assay, for all clinical chemistry analysers, offers a linear range of 20 to 8,000 µg/g. In 2020 BÜHLMANN launches additionally the BÜHLMANN fPELA® turbo test for the turbidimetric assessment of Exocrine Pancreatic Insufficiency for very fast results. The unique CALEX® extraction device allows for clean, precise and easy stool collection and stabilization of both analytes. Calprotectin is also available as ELISA, as rapid tests (Quantum Blue®) and for home diagnostics (IBDoc®). With the Quantum Blue® Infliximab and Adalimumab rapid tests for therapeutic drug monitoring BÜHLMANN exclusively offers a comprehensive patient monitoring menu from lab to home testing. Other BÜHLMANN key areas are Neuroimmunology, with the BÜHLMANN GanglioCombi® MAG ELISA, Allergy, with routine friendly Flow CAST® Basophil Activation Tests and allergen menu, as well as being the world leader for ACE and GHB for clinical chemistry. BÜHLMANN is fully independent, globally active and based in Switzerland.